ZJJF(SH:600668)2022-04-18 16:00Financial Performance - The company's operating revenue for 2021 was CNY 380,503.81 million, representing a 17.17% increase compared to CNY 324,747.27 million in 2020[20]. - The net profit attributable to shareholders for 2021 was CNY 92,407.89 million, a significant increase of 58.12% from CNY 58,442.02 million in 2020[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 63,464.71 million, up 22.32% from CNY 51,886.27 million in 2020[20]. - The net cash flow from operating activities for 2021 was CNY 47,535.01 million, a decrease of 22.59% compared to CNY 61,404.69 million in 2020[20]. - The total assets at the end of 2021 were CNY 702,443.51 million, reflecting a 10.74% increase from CNY 634,340.32 million at the end of 2020[20]. - The net assets attributable to shareholders at the end of 2021 were CNY 520,703.62 million, which is a 17.39% increase from CNY 443,550.00 million at the end of 2020[20]. - Basic earnings per share (EPS) for 2021 was 2.6856 RMB, up 58.12% from 1.6985 RMB in 2020[21]. - The diluted EPS also stood at 2.6856 RMB, reflecting the same growth rate of 58.12%[21]. - The weighted average return on equity (ROE) was 19.32%, an increase of 5.08 percentage points from 14.24% in 2020[21]. - The company achieved a total revenue of 3.805 billion RMB, representing a year-on-year growth of 17.17%[44]. Dividend and Capital Management - The company plans to distribute a cash dividend of CNY 5.0 per 10 shares, totaling CNY 172,041,914.00 to shareholders[6]. - The company does not plan to increase capital from reserves for the 2021 fiscal year[6]. - The company has established a cash dividend policy that mandates a minimum of 30% of the average distributable profit over the last three years to be distributed in cash[150]. Research and Development - Research and development expenses increased by 31.97% to 99.34 million RMB, driven by new product development investments[46]. - The total research and development investment amounted to 12,864.05 million, representing 3.38% of total revenue[59]. - The company aims to enhance its R&D capabilities by leveraging platforms such as the Academician Expert Workstation and Zhejiang New Drug R&D Center, focusing on attracting high-level talent[80]. - The company is focusing on a "4+2" new drug research and development strategy, leveraging partnerships with renowned research institutions to enhance product development efficiency[117]. Market and Product Development - The company plans to continue focusing on innovation and high-quality development in line with the national economic strategy[29]. - The company has launched six functional food products, including coenzyme Q10 soft capsules and collagen liquid drinks, expanding its health product offerings[32]. - The company is actively participating in the major asset restructuring of Tianshan Shares, yielding favorable investment returns[30]. - The company is investing in the construction of a production base with an annual capacity of 2 billion solid preparations, with an investment of 90.81 million RMB during the reporting period[96]. Environmental and Social Responsibility - The company emphasizes environmental protection and clean production, actively fulfilling its social responsibility[160]. - The company has implemented energy-saving measures, including the use of low-temperature waste heat power generation systems in its new cement production lines[176]. - The company actively participates in social responsibility initiatives, contributing over 2 million RMB to various charitable activities during the reporting period[179]. - The company has created over 130 local jobs in Guizhou, contributing to poverty alleviation and economic development in the region[180]. Risk Management and Compliance - The company has disclosed potential risks in its future development in the management discussion and analysis section[8]. - The company is facing risks from economic cycle fluctuations, particularly in the cement industry, which is closely tied to national economic growth[114]. - The company has a robust governance structure, ensuring compliance with laws and regulations while protecting minority shareholders' rights[122]. - The company has not faced any regulatory penalties for information disclosure violations during the reporting period, maintaining a high standard of transparency[125]. Strategic Initiatives - The company plans to enhance customer engagement through digital platforms, targeting a 40% increase in online interactions[131]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $100 million allocated for potential mergers[131]. - The management emphasized the importance of sustainability initiatives, aiming to reduce carbon emissions by 30% over the next five years[131]. - The company aims to achieve a sales revenue of 4 billion yuan in 2022, with continuous improvement in financial and economic indicators[109].